Eterna Therapeutics Inc. (NASDAQ: ERNA) Stock Information | RedChip

Eterna Therapeutics Inc. (NASDAQ: ERNA)


$0.2573
+0.0083 ( +0.90% ) 124.2K

Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.

Market Data


Open


$0.2573

Previous close


$0.2490

Volume


124.2K

Market cap


$12.79M

Day range


$0.2430 - $0.2600

52 week range


$0.2212 - $2.6250

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 84 Aug 13, 2024
4 Insider transactions 1 Jun 25, 2024
10-q Quarterly Reports 77 May 14, 2024
4 Insider transactions 1 Apr 29, 2024
4 Insider transactions 1 Apr 29, 2024
4 Insider transactions 1 Apr 29, 2024
8-k 8K-related 13 Mar 22, 2024
10-k/a Quarterly Reports 17 Mar 18, 2024
10-k Annual reports 113 Mar 14, 2024
8-k 8K-related 14 Feb 16, 2024

Latest News